10 research outputs found
Immunoregulatory activities of nanoparticle-forming oligodeoxynucleotides
Ankara : The Department of Moleculer Biology and Genetics and the Institute of Engineering and Science of Bilkent University, 2009.Thesis (Master's) -- Bilkent University, 2009.Includes bibliographical references leaves 84-95.Innate immune system is activated by a wide range of microbial by products leading to
an immediate immune activation primarily designed to neutralize and control the invading insult.
The cells of the innate immune system also instruct the development of antigen-specific adaptive
immunity. While TLR9 is triggered by bacterial DNA, extended and over-exuberant immune
response poses a threat since it may exacerbate cell and tissue destruction leading to organ
failure. Telomeric TTAGGG conserved motifs are previously reported to antagonize TLR
mediated events. The down-regulatory effect of these motifs may help to restore the desired
homeostatic balance of the immune system. While CpG ODN patterned after bacterial DNA can
be harnessed in different clinical settings to provide an advantage to host to resist infectious
diseases, control tumor growth or alleviate allergic symptoms, the immunosuppressive telomeric
motifs could be effectively applied in controlling systemic anti-inflammatory or autoimmune
related disorders.
Several challenges exist in the utilization of synthetic ODNs in the clinic. The first
challenge is that conventional classes of synthetic ODNs exhibit different properties. K-type
ODNs are more effective in proliferation and activation of B cells and DC. D-type ODNs are in
nanoparticle forms, lead to anti-viral type I IFN production and mature monocytes into DCs. Of
note, the efficacy of these synthetic ODNs is reduced under physiological conditions due to
premature clearance and low levels of internalization. Moreover, D-ODNs as one of the most
potent IFNα inducing TLR9 ligands possess a large-scale production problem due to 3’polyGruns,
which hamper their entry into the clinic.
We have designed a novel class of ODN, designated as ODN420, devoid of polyGs that
can undergo nanoparticle formation necessary for its IFNα induction. Ex vivo stimulation of
mouse splenocytes and in vivo administration of ODN420 have revealed that this ODN exhibits
higher immunostimulatory potential and is more stable than most commonly used ODNs due to
its nanoparticle-forming ability. Another interesting finding is that ODN420 with the natural
phosphodiester (PO) backbone is at least as potent as its more stable counterpart with the
modified phosphorothioate backbone. Furthermore, it combines superior properties of
conventional classes of K and D-ODNs. These results have been reproduced in human peripheral
blood mononuclear cells by various assays.
Next, we have analyzed whether this ODN could be utilized as a vaccine adjuvant and an
anti-cancer agent with two independent experiments. Our immunization results demonstrate that
ODN420 induces a higher level of Th1-mediated response than conventional ODNs and is a
promising candidate as a vaccine adjuvant. This response is hampered when ODN420 is used in
combination with ODN-A151. In the tumor xenograft model, ODN420 has promoted partial
remission of the tumors or delayed the tumor growth. This knowledge will pave the way for
more effective immunotherapeutic approaches.Karatepe, KutayM.S
Human neutrophil development and functionality are enabled in a humanized mouse model
Mice with a functional human immune system serve as an invaluable tool to study the development and function of the human immune system in vivo. A major technological limitation of all current humanized mouse models is the lack of mature and functional human neutrophils in circulation and tissues. To overcome this, we generated a humanized mouse model named MISTRGGR, in which the mouse granulocyte colony-stimulating factor (G-CSF) was replaced with human G-CSF and the mouse G-CSF receptor gene was deleted in existing MISTRG mice. By targeting the G-CSF cytokine-receptor axis, we dramatically improved the reconstitution of mature circulating and tissue-infiltrating human neutrophils in MISTRGGR mice. Moreover, these functional human neutrophils in MISTRGGR are recruited upon inflammatory and infectious challenges and help reduce bacterial burden. MISTRGGR mice represent a unique mouse model that finally permits the study of human neutrophils in health and disease
Role of Selenof as a Gatekeeper of Secreted Disulfide-Rich Glycoproteins
Selenof (15-kDa selenoprotein; Sep15) is an endoplasmic reticulum (ER)-resident thioredoxin-like oxidoreductase that occurs in a complex with UDPglucose: glycoprotein glucosyltransferase. We found that Selenof deficiency in mice leads to elevated levels of non-functional circulating plasma immunoglobulins and increased secretion of IgM during in vitro splenic B cell differentiation. However, Selenof knockout animals show neither enhanced bacterial killing capacity nor antigen-induced systemic IgM activity, suggesting that excess immunoglobulins are not functional. In addition, ER-to-Golgi transport of a target glycoprotein was delayed in Selenof knockout embryonic fibroblasts, and proteomic analyses revealed that Selenof deficiency is primarily associated with antigen presentation and ER-to-Golgi transport. Together, the data suggest that Selenof functions as a gatekeeper of immunoglobulins and, likely, other client proteins that exit the ER, thereby supporting redox quality control of these proteins
G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling
Recommended from our members
Role of Proteinase 3 in bone marrow hematopoiesis and neutrophil function
The hematopoietic system requires finely-tuned regulatory mechanisms to supply the continuous demand of short-lived blood cells while maintaining a healthy hematopoietic stem cell compartment. Proteinase 3 (PR3), a member of neutrophil serine proteases, has a unique role in the regulation of hematopoiesis among its family members. PR3, which has been thought to be expressed exclusively in mature myeloid cells and myeloid progenitors, is expressed in hematopoietic stem cells. PR3 deletion expanded the hematopoietic stem and progenitor cell compartments. Absence of PR3 led to increased short-term regeneration potential, accompanied with a defect in production of lymphoid cells, particularly T cells. A more focused analysis led to identification of reduced cell death due to a defect in caspase 3 cleavage, but not proliferation, as the mechanism for elevated hematopoiesis seen in PR3 deficiency. PR3-deficient hematopoietic stem cells displayed exacerbated features associated with ageing. In spite of the previously proposed roles of PR3 in neutrophil function such as microbicidal activity, PR3 deficiency did not reveal a major defect in neutrophil functions except for IL1β secretion. Overall, this study identifies PR3 as a physiological regulator of hematopoietic stem cell compartment and function.Biological Sciences in Public Healt
Role of Selenof as a Gatekeeper of Secreted Disulfide-Rich Glycoproteins
Selenof (15-kDa selenoprotein; Sep15) is an endoplasmic reticulum (ER)-resident thioredoxin-like oxidoreductase that occurs in a complex with UDPglucose: glycoprotein glucosyltransferase. We found that Selenof deficiency in mice leads to elevated levels of non-functional circulating plasma immunoglobulins and increased secretion of IgM during in vitro splenic B cell differentiation. However, Selenof knockout animals show neither enhanced bacterial killing capacity nor antigen-induced systemic IgM activity, suggesting that excess immunoglobulins are not functional. In addition, ER-to-Golgi transport of a target glycoprotein was delayed in Selenof knockout embryonic fibroblasts, and proteomic analyses revealed that Selenof deficiency is primarily associated with antigen presentation and ER-to-Golgi transport. Together, the data suggest that Selenof functions as a gatekeeper of immunoglobulins and, likely, other client proteins that exit the ER, thereby supporting redox quality control of these proteins
Proteinase 3 Limits the Number of Hematopoietic Stem and Progenitor Cells in Murine Bone Marrow
Summary: Hematopoietic stem and progenitor cells (HSPCs) undergo self-renewal and differentiation to guarantee a constant supply of short-lived blood cells. Both intrinsic and extrinsic factors determine HSPC fate, but the underlying mechanisms remain elusive. Here, we report that Proteinase 3 (PR3), a serine protease mainly confined to granulocytes, is also expressed in HSPCs. PR3 deficiency intrinsically suppressed cleavage and activation of caspase-3, leading to expansion of the bone marrow (BM) HSPC population due to decreased apoptosis. PR3-deficient HSPCs outcompete the long-term reconstitution potential of wild-type counterparts. Collectively, our results establish PR3 as a physiological regulator of HSPC numbers. PR3 inhibition is a potential therapeutic target to accelerate and increase the efficiency of BM reconstitution during transplantation. : In this article, Luo and colleagues show that Proteinase 3 (PR3), a member of neutrophil serine proteases, is expressed in HSPCs and regulates HSPC numbers in murine bone marrow. Their results suggest that PR3 deficiency does not affect HSPC proliferation but reduces the rate of spontaneous HSPC apoptosis by cleaving and activating caspase-3. Keywords: Proteinase 3, hematopoiesis, hematopoietic stem cell, hematopoietic progenitor cell, apoptosi
Recommended from our members
G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling
Cytokine-induced neutrophil mobilization from the bone marrow to circulation is a critical event in acute inflammation, but how it is accurately controlled remains poorly understood. In this study, we report that CXCR2 ligands are responsible for rapid neutrophil mobilization during early-stage acute inflammation. Nevertheless, although serum CXCR2 ligand concentrations increased during inflammation, neutrophil mobilization slowed after an initial acute fast phase, suggesting a suppression of neutrophil response to CXCR2 ligands after the acute phase. We demonstrate that granulocyte colony-stimulating factor (G-CSF), usually considered a prototypical neutrophil-mobilizing cytokine, was expressed later in the acute inflammatory response and unexpectedly impeded CXCR2-induced neutrophil mobilization by negatively regulating CXCR2-mediated intracellular signaling. Blocking G-CSF in vivo paradoxically elevated peripheral blood neutrophil counts in mice injected intraperitoneally with Escherichia coli and sequestered large numbers of neutrophils in the lungs, leading to sterile pulmonary inflammation. In a lipopolysaccharide-induced acute lung injury model, the homeostatic imbalance caused by G-CSF blockade enhanced neutrophil accumulation, edema, and inflammation in the lungs and ultimately led to significant lung damage. Thus, physiologically produced G-CSF not only acts as a neutrophil mobilizer at the relatively late stage of acute inflammation, but also prevents exaggerated neutrophil mobilization and the associated inflammation-induced tissue damage during early-phase infection and inflammation